Bamba, Shigeki http://orcid.org/0000-0002-4108-5894
Sakemi, Ryosuke
Fujii, Toshimitsu
Takeda, Teruyuki
Fujioka, Shin
Takenaka, Kento
Kitamoto, Hiroki
Umezawa, Shotaro
Sakuraba, Hirotake
Inokuchi, Toshihiro
Fukata, Norimasa
Mizuno, Shinta
Yamashita, Masaki
Shinzaki, Shinichiro
Tanaka, Hiroki
Takedatsu, Hidetoshi
Ozaki, Ryo
Moriya, Kei
Ishii, Manabu
Kinjo, Tetsu
Ozeki, Keiji
Ooi, Makoto
Hayashi, Ryohei
Kakimoto, Kazuki
Shimodate, Yuichi
Kitamura, Kazuya
Yamada, Akihiro
Sonoda, Akira
Nishida, Yu
Yoshioka, Kyouko
Ashizuka, Shinya
Takahashi, Fumiaki
Shimokawa, Toshio
Kobayashi, Taku
Andoh, Akira
Hibi, Toshifumi
Article History
Received: 11 May 2019
Accepted: 9 January 2020
First Online: 27 January 2020
Compliance with ethical standards
:
: SB received lecture fees from AbbVie GK, Mitsubishi Tanabe Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Janssen, Mochida Pharmaceutical, Nippon Kayaku, Zeria Pharmaceutical Co., Ltd., and EA Pharma Co., Ltd., and research support from AbbVie GK, and MSD Inc. RS received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd., Janssen, AbbVie GK, EA Pharma Co., Ltd., and Nippon Kayaku. TF received research support from Eisai Co., Ltd., and Alfresa Co., Ltd., and lecture fees from AbbVie, Ajinomoto Pharma, Boehringer Ingelheim, Daiichi Sankyo Co., Ltd., EA Pharma Co., Ltd., Janssen, Kissei Pharmaceutical, Kyorin Pharmaceutical Co., Ltd., Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma Co., Ltd., Mochida Pharmaceutical, Nippon Kayaku, and Zeria Pharmaceutical Co., Ltd. HS received research support from Bristol-Myers Squibb, AbbVie GK, MSD Inc., Daiichi Sankyo Co., Ltd., and Zeria Pharmaceutical Co., Ltd. SS received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd., AbbVie GK, EA Pharma Co., Ltd., and Nippon Kayaku. HTan received lecture fees from JIMRO Co., Ltd., AbbVie GK, EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma Co., Ltd. RO received lecture fees from AbbVie GK. KKa received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd. and AbbVie GK. YS received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd. and EA Pharma Co., Ltd. KKi received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd., AbbVie GK, EA Pharma Co., Ltd., Janssen, Nippon Kayaku, and Olympus, and research support from AbbVie GK and Zeria Pharmaceutical. SA received lecture fees from Janssen, Mitsubishi Tanabe Pharma Co., Ltd., and JIMRO Co., Ltd. TKo received lecture fees from AbbVie GK, Ajinomoto Pharma, Asahi Kasei Medical, Astellas, Alfresa Pharma, Celltrion, EA Pharma Co., Ltd., Eisai Co., Ltd., Gilead Sciences, Janssen, JIMRO Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku, Mochida Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Co., Ltd., and ZERIA Pharmaceutical Co., Ltd., and consulting fees from Alfresa Pharma, Covidien, Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda Pharmaceutical, and Thermo Scientific, and research support from EA Pharma Co., Ltd., Thermo Fisher Scientific, Alfresa Pharma, Nippon Kayaku, and Asahi Kasei Medical. AA received lecture fees from AbbVie GK, Mitsubishi Tanabe Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Janssen, Astellas, Zeria Pharmaceutical, Miyarisan Pharmaceutical, Takeda Pharmaceutical, Bristol-Myers Squibb, Gilead Sciences, MSD Inc., and EA Pharma Co., Ltd., and research support from EA Pharma Co., Ltd., AbbVie GK, MSD Inc., and Mochida Pharmaceutical, and consulting fees from Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical. TH received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., AbbVie GK, Janssen, JIMRO Co., Ltd., EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical, Gilead Sciences, Celltrion, Nippon Kayaku, Kissei Pharmaceutical, Miyarisan Pharmaceutical, Zeria Pharmaceutical Co., Ltd., and Ferring Pharmaceutical, and advisory/consultancy fees from AbbVie GK, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Co., Ltd., JIMRO Co., Ltd., EA Pharma Co., Ltd., Eli Lilly, Pfizer Japan Inc, Nichi-Iko Pharmaceutical, and Nippon Kayaku, and research support from EA Pharma, AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co. Ltd., and Otsuka Pharmaceutical Co., Ltd. However, none of the above is relevant to this article.